Regeneron Competitors

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Regeneron Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Regeneron Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
612.55614.57616.59
Details
Intrinsic
Valuation
LowReal ValueHigh
552.25662.09664.11
Details
Naive
Forecast
LowNext ValueHigh
649.21651.23653.25
Details
15 Analysts
Consensus
LowTarget PriceHigh
575.00706.85844.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Regeneron Pharmaceuticals. Your research has to be compared to or analyzed against Regeneron Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Regeneron Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Regeneron Pharmaceuticals.

Regeneron Pharmaceuticals Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Regeneron Pharmaceuticals and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Regeneron and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Regeneron Pharmaceuticals does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Regeneron Pharmaceuticals Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Regeneron Pharmaceuticals stock performing well and Regeneron Pharmaceuticals company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Regeneron Pharmaceuticals' multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
PFE 1.29  0.04  0.02  0.04  1.67  0.0261 (1.25)  2.93 (2.43)  7.74 
SBUX 1.89  0.28  0.11  0.17  2.13  0.1 (1.92)  4.12 (4.21)  14.93 
T 1.15 (0.04)  0.00 (0.08)  0.00 (0.0233)  0.00  2.20 (2.45)  10.81 
DIS 1.78 (0.06)  0.00 (0.06)  0.00 (0.0299)  0.00  3.73 (3.76)  7.34 
CVX 1.91 (0.04)  0.00 (0.05)  0.00 (0.0144)  0.00  3.14 (4.57)  11.62 
AXP 1.89 (0.09)  0.00 (0.08)  0.00 (0.0398)  0.00  3.79 (3.84)  9.74 
XOM 2.10  0.06  0.02  0.05  2.98  0.0228 (1.93)  3.97 (4.21)  11.86 
IBM 1.20  0.03  0.02  0.04  1.80  0.0228 (1.13)  2.10 (2.48)  8.93 

Cross Equities Net Income Analysis

Compare Regeneron Pharmaceuticals and related stocks such as Pfizer Inc, Starbucks Corp, ATT Inc, Walt Disney, Chevron Corp, American Express, Exxon Mobil Corp, and International Business Net Income Over Time
Select Fundamental

2010201120122013201420152016201720182019202020212022
PFE8.3 B10 B14.6 B22 B9.1 BB7.2 B21.3 B11.2 B16.3 B9.6 B22 B23.7 B
SBUX2.9 B2.9 B2.9 B2.9 B2.9 B2.9 B2.9 B4.2 B4.2 B4.2 B4.2 B4.5 B4.9 B
T19.9 B3.9 B7.3 B18.2 B6.2 B13.3 B13 B29.4 B19.4 B13.9 B(5.2 B)20.1 B16.2 B
DIS4.8 B9.4 B9.4 B9.4 B9.4 B9.4 BBBBBBB7.5 B
CVX26.9 B26.9 B26.2 B21.4 B19.2 B4.6 B(497 M)9.2 B14.8 B2.9 B(5.5 B)15.6 B13.4 B
AXP4.9 B4.9 B4.5 B5.4 B5.9 B5.2 B5.4 B2.7 B6.9 B6.8 B3.1 B8.1 B7.3 B
XOM30.5 B41.1 B44.9 B32.6 B32.5 B16.1 B7.8 B19.7 B20.8 B14.3 B(22.4 B)23 B24.7 B
IBM15.9 B15.9 B16.6 B16.5 B12 B13.2 B11.9 B5.8 B8.7 B9.4 B5.6 B5.7 B7.7 B

Regeneron Pharmaceuticals and related stocks such as Pfizer Inc, Starbucks Corp, ATT Inc, Walt Disney, Chevron Corp, American Express, Exxon Mobil Corp, and International Business Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Regeneron Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Regeneron Pharmaceuticals operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Regeneron Pharmaceuticals Competitive Analysis

The better you understand Regeneron Pharmaceuticals competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Regeneron Pharmaceuticals' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Regeneron Pharmaceuticals' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
REGNPFESBUXTDISCVXAXPXOMIBM
 0.22 
 613.61 
Regeneron
 1.18 
 49.27 
Pfizer
 1.32 
 85.73 
Starbucks
 0.44 
 18.35 
ATT
 1.38 
 106.63 
Disney
 1.65 
 153.64 
Chevron
 0.41 
 157.51 
American
 1.45 
 88.45 
Exxon
 0.64 
 132.48 
International
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Stock Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Profit Margin
EBITDA
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Five Year Return
Beta
Price to Book
Shares Outstanding
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Price to Earnings To Growth
Current Liabilities
Total Asset
Short Ratio
Last Dividend Paid
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Regeneron Pharmaceuticals Competition Performance Charts

Complement your Regeneron Pharmaceuticals position

In addition to having Regeneron Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Recreation Thematic Idea Now

Recreation
Recreation Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Recreation theme has 56 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recreation Theme or any other thematic opportunities.
View All  Next Launch
Additionally, take a look at Regeneron Pharmaceuticals Correlation with its peers. Note that the Regeneron Pharmaceuticals information on this page should be used as a complementary analysis to other Regeneron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Regeneron Stock analysis

When running Regeneron Pharmaceuticals price analysis, check to measure Regeneron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regeneron Pharmaceuticals is operating at the current time. Most of Regeneron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Regeneron Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Regeneron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Regeneron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Is Regeneron Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.72
Market Capitalization
65.7 B
Quarterly Revenue Growth YOY
-0.44
Return On Assets
0.18
Return On Equity
0.32
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Regeneron Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
REGN
 Stock
  

USD 613.61  1.35  0.22%   

Regeneron Pharmaceuticals competes with Pfizer, Starbucks Corp, ATT, Disney, and Chevron Corp; as well as few others. The company conducts business under Healthcare sector and is part of Biotechnology industry. Analyzing Regeneron Pharmaceuticals competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Regeneron Pharmaceuticals to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Regeneron Pharmaceuticals competition on your existing holdings. Additionally, take a look at Regeneron Pharmaceuticals Correlation with its peers.
  
Return on Investment is expected to rise to 56.00 this year. Return on Average Assets is expected to rise to 40.91 this year. Regeneron Pharmaceuticals Return on Average Assets are quite stable at the moment as compared to the past year. The company's current value of Return on Average Assets is estimated at 40.91. Tangible Assets Book Value per Share is expected to rise to 64.42 this year, although the value of Revenue to Assets will most likely fall to 0.59.